For the Inventor, By the Inventor

Enter inventor name

Hong Kong, China

Yutian Wei

USPTO Granted Patents = 12 (Patent Applications = 10)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 8.1

ph-index = 5

Forward Citations = 35(Granted Patents)

Location History:

Shanghai, CN (2021 - 2023)
Hong Kong, CN (2021 - 2023)

Company Filing History:

Cellular Biomedicine Group Hk Limited

Cellular Biomedicine Group, Inc.

Years Active: 2021-2025

Loading Chart...

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448432 - Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof (2025-10-21),

2. 12338494 - Reagent and method for fluorescence quantitative real-time PCR detection of RCL (2025-06-24),

3. 11697848 - Reagent and method for fluorescence quantitative real-time PCR detection of RCL (2023-07-11),

4. 11633430 - Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof (2023-04-25),

5. 11618778 - Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof (2023-04-04),

6. 11608369 - Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof (2023-03-21),

7. 11498973 - BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof (2022-11-15),

8. 11472858 - Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof (2022-10-18),

9. 11439665 - Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof (2022-09-13),

10. 11207349 - Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof (2021-12-28),

11. 11142581 - BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof (2021-10-12),

12. 11066457 - Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof (2021-07-20),

Title: The Innovative Journey of Yutian Wei

Introduction: Yutian Wei, a visionary inventor hailing from Hong Kong, CN, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Yutian Wei's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics and a revolutionary wearable device for monitoring vital signs in real-time.

Career Highlights: With a career spanning over two decades, Yutian Wei has established himself as a pioneer in the tech industry, holding numerous patents in areas such as machine learning, IoT, and biotechnology. His innovative solutions have garnered international recognition and acclaim.

Collaborations: Yutian Wei has collaborated with leading research institutions, universities, and tech companies to further advance his inventions. His partnerships have led to the development of cutting-edge technologies that have reshaped industries and improved the lives of many.

Conclusion: Yutian Wei's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a trailblazing inventor in the global tech landscape. His contributions continue to inspire future generations of inventors and shape the world of tomorrow.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…